Clinical Trial Update: Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation [NA]

View source ↗

Summary

Clinical trial update on mismatched donor lymphocyte infusions for relapse after allogeneic stem cell transplantation; status completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia Lymphoblastic Acute
• Leukemia Myelocytic Chronic
• Leukemia Myeloid Acute

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute | NA | Status: COMPLETED | Results posted: 2015-11-06